Independent Pharmacy: Rising to Meet the Challenge of the Future

REFERENCES

• NARD. 1994 NARD-Lilly Digest.
   Google Scholar
• Trinca CE. The pharmacist's progress towards implementing pharmaceuti-cal care. Unpublished.
   Google Scholar
• Smith MC. The view from Sledge. PM Pharrn Manage J 1967;(Jul):13.
   Google Scholar
• Anon. Serving the growing senior market. NARD J 1990;112(8):47–50.
   Google Scholar
• Sonnedecker G, ed. Kremers and Urdang's history of pharmacy. 4th ed. Philadelphia: JB Lippincott, 1976.
   Google Scholar
• Carroll NV, Jowdy AW. Demographic and prescription patronage motive differences among segments in the community pharmacy market. J Phann Market Manage 1987; 1(4):19–33.
   Google Scholar
• Anon. Annual report: facts and figures. Drug Store News Phann 1994;4(4):38.
   Google Scholar
• NABP. 1994 NABP Survey of Pharmacy Law.
   Google Scholar
• McKay AB. Entrepreneurship. NARD Management Institute course.
   Google Scholar
• Anon. Third parties pay for 1 out of every 4 Rxs. Am Druggist 1975; 172(2):56+.
   Google Scholar
• Carroll NV. Forecasting the impact of participation in third-party prescrip-tion programs on pharmacy profits. J Res Pharm Econ 1991;3(3):3–23.
   Google Scholar
• American Pharmaceutical Association. Opportunities for the community pharmacist in managed care. Washington, DC: American Pharmaceutical Association, 1994.
   Google Scholar
• Biro S. Reimbursement to pharmacists has not increased Medicaid costs in past 10 years. Pharm Today 1995;1(4):22–3.
   Google Scholar
• Banahan BF III, Basara LR. Therapeutic recommendations: the future of clinical community pharmacy practice. Am Druggist 1994;211(1):75–82.
   Google Scholar
• Porter ME. The competitive advantage of nations. New York: The Free Press, 1990.
   Google Scholar
• Gooen LG. Consultant phaimacy: an evolving practice. Phatm Times 199056( I 1):47–53.
   Google Scholar
• Lipton HL. The graying of America: implications for the pharmacist. Am Hosp Pharm 1982;39:131–5.
   PubMedGoogle Scholar
• Naisbitt J. Megatrends: ten new directions transforming our lives. New York: Warner Books, 1984.
   Google Scholar
• Bezold C. Future trends in self-medication and self-care. I Soc Admin Pharm 19907:205–15.
   Google Scholar
• Holt C. Focusing on pharmacy's future: what things will look like in the year 2000. Am Druggist 1995;211(3):20–3.
   Google Scholar
• Christensen DB, Fassett WE, Andrews GA. A practical billing and pay-ment plan for cognitive services. Am Pharm 1993;NS33(3):34–40.
   Google Scholar
• Banahan BF Ill, McCaffrey DJ III, Kolassa EM. Community pharmacists' attitudes toward and involvement in therapeutic recommendations and cognitive service reimbursement programs. University, MS: University of Mississippi, 1995.
   Google Scholar
• Banahan BF III, McCaffrey DJ III. Pharmacists' growing influence on MDs' product selection. Pharm Times 1993;59(8):28–40.
   Google Scholar
• Debrovner D. Did you . take your pill today? Am Druggist 1992; 206(6):60–6.
   Google Scholar
• Anon. Flash point: pill patrol. Am Druggist 1992;206(6):60–6.
   Google Scholar
• Basara LR, Smith MC. Community pharmacists' attitudes toward compa-ny sponsored patient programs. Unpublished.
   Google Scholar
• Ukens C. Whatever happened to pharmaceutical care? Drug Top 1994;138 (5):38–52.
   Google Scholar
• Summers K. Getting reimbursed for nondispensing services. Thug Top 1993;137 (17):74–86.
   Google Scholar
• NARD news release: the costs and consequences of drug noncompliance.
   Google Scholar
• Anon. Controlling health care costs through comprehensive pharmacy care. Alexandria, VA: NARD, 1992.
   Google Scholar
• Dobie FtL, Rascati KL. Doctunenting the value of pharmacist interven-tions. Am Pharm 1994;NS34(5):50–4.
   Google Scholar
• Rupp MT. Evaluation of prescribing errors and pharmacist interventions in community practice: an estimate of "value added." Am Pharm 1988;NS28(12):22–6.
   Google Scholar
• Meade V. Getting paid for cognitive services. Am Pharm 1994;NS34(6):32–6.
   Google Scholar
• Cardinale V. Cognitive-pay movement gains momentum, APhA told. Drug Top 1994;138(8):79–80.
   Google Scholar
• Felkey B, Schondelmeyer S. Berger B. Invoicing pharmacist interventions. Am Pharm 1994;NS34(6):37–8.
   Google Scholar
• Rosendahl L Preventive care: a promise of opportunity. Drug Top 1994;138 (1):42–52.
   Google Scholar
• Anon. Independent pharmacy ownership: forging pharmacy's future. NARD J 1992;114(4)18–28.
   Google Scholar